# Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

> **NCT01674855** · PHASE3 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 74 (estimated)

## Conditions studied

- Chemotherapy Induced Neutropenia

## Interventions

- **DRUG:** PEG-G-CSF
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT01674855
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-05
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674855, "Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01674855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*